1. Home
  2. GKOS vs CRL Comparison

GKOS vs CRL Comparison

Compare GKOS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CRL
  • Stock Information
  • Founded
  • GKOS 1998
  • CRL 1947
  • Country
  • GKOS United States
  • CRL United States
  • Employees
  • GKOS N/A
  • CRL N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • GKOS Health Care
  • CRL Health Care
  • Exchange
  • GKOS Nasdaq
  • CRL Nasdaq
  • Market Cap
  • GKOS 8.4B
  • CRL 9.3B
  • IPO Year
  • GKOS 2015
  • CRL 2000
  • Fundamental
  • Price
  • GKOS $156.36
  • CRL $163.53
  • Analyst Decision
  • GKOS Strong Buy
  • CRL Hold
  • Analyst Count
  • GKOS 13
  • CRL 15
  • Target Price
  • GKOS $147.23
  • CRL $209.42
  • AVG Volume (30 Days)
  • GKOS 662.3K
  • CRL 808.9K
  • Earning Date
  • GKOS 02-19-2025
  • CRL 02-12-2025
  • Dividend Yield
  • GKOS N/A
  • CRL N/A
  • EPS Growth
  • GKOS N/A
  • CRL N/A
  • EPS
  • GKOS N/A
  • CRL 8.00
  • Revenue
  • GKOS $360,347,000.00
  • CRL $4,060,916,000.00
  • Revenue This Year
  • GKOS $22.69
  • CRL N/A
  • Revenue Next Year
  • GKOS $26.76
  • CRL $1.18
  • P/E Ratio
  • GKOS N/A
  • CRL $20.43
  • Revenue Growth
  • GKOS 18.70
  • CRL N/A
  • 52 Week Low
  • GKOS $83.90
  • CRL $160.85
  • 52 Week High
  • GKOS $161.13
  • CRL $275.00
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.10
  • CRL 27.35
  • Support Level
  • GKOS $142.71
  • CRL $160.85
  • Resistance Level
  • GKOS $158.01
  • CRL $190.68
  • Average True Range (ATR)
  • GKOS 4.96
  • CRL 5.76
  • MACD
  • GKOS -0.16
  • CRL -2.10
  • Stochastic Oscillator
  • GKOS 74.10
  • CRL 8.19

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: